Respiratory Syncytial Virus (RSV) Therapeutics Market Report

Global and Region Respiratory Syncytial Virus (RSV) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：140
  • REPORT CODE：GMM897589
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Respiratory Syncytial Virus (RSV) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Respiratory Syncytial Virus (RSV) Therapeuticsmarket, defines the market attractiveness level of Respiratory Syncytial Virus (RSV) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Respiratory Syncytial Virus (RSV) Therapeutics industry, describes the types of Respiratory Syncytial Virus (RSV) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Respiratory Syncytial Virus (RSV) Therapeutics market and the development prospects and opportunities of Respiratory Syncytial Virus (RSV) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Respiratory Syncytial Virus (RSV) Therapeutics market in Chapter 13.

    By Player:

    • Johnson and Johnson Services Inc (US)

    • Merck & Co, Inc (US)

    • Celltrion Inc (South Korea)

    • Bausch Health Companies Inc (US)

    • Enanta Pharmaceuticals, Inc (US)

    • AstraZeneca (UK)

    • Sanofi (France)

    • AbbVie (US)

    • mAbxience (Spain)

    By Type:

    • Palivizumab

    • Ribavirin

    • Others

    By End-User:

    • Hospital Pharmacies

    • Drug Stores

    • Retail Pharmacies

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Respiratory Syncytial Virus (RSV) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Respiratory Syncytial Virus (RSV) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Respiratory Syncytial Virus (RSV) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Respiratory Syncytial Virus (RSV) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.2 United States Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.4 China Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.6 India Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Respiratory Syncytial Virus (RSV) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Respiratory Syncytial Virus (RSV) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast (2022-2028)

    9 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Palivizumab Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ribavirin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Palivizumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ribavirin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Respiratory Syncytial Virus (RSV) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Respiratory Syncytial Virus (RSV) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Respiratory Syncytial Virus (RSV) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Respiratory Syncytial Virus (RSV) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Respiratory Syncytial Virus (RSV) Therapeutics Market Competitive Analysis

    • 14.1 Johnson and Johnson Services Inc (US)

      • 14.1.1 Johnson and Johnson Services Inc (US) Company Details

      • 14.1.2 Johnson and Johnson Services Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Johnson and Johnson Services Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.2 Merck & Co, Inc (US)

      • 14.2.1 Merck & Co, Inc (US) Company Details

      • 14.2.2 Merck & Co, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.3 Celltrion Inc (South Korea)

      • 14.3.1 Celltrion Inc (South Korea) Company Details

      • 14.3.2 Celltrion Inc (South Korea) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Celltrion Inc (South Korea) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.4 Bausch Health Companies Inc (US)

      • 14.4.1 Bausch Health Companies Inc (US) Company Details

      • 14.4.2 Bausch Health Companies Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bausch Health Companies Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.5 Enanta Pharmaceuticals, Inc (US)

      • 14.5.1 Enanta Pharmaceuticals, Inc (US) Company Details

      • 14.5.2 Enanta Pharmaceuticals, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Enanta Pharmaceuticals, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.6 AstraZeneca (UK)

      • 14.6.1 AstraZeneca (UK) Company Details

      • 14.6.2 AstraZeneca (UK) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca (UK) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.7 Sanofi (France)

      • 14.7.1 Sanofi (France) Company Details

      • 14.7.2 Sanofi (France) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi (France) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.8 AbbVie (US)

      • 14.8.1 AbbVie (US) Company Details

      • 14.8.2 AbbVie (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AbbVie (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • 14.9 mAbxience (Spain)

      • 14.9.1 mAbxience (Spain) Company Details

      • 14.9.2 mAbxience (Spain) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 mAbxience (Spain) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Respiratory Syncytial Virus (RSV) Therapeutics

    • Figure Respiratory Syncytial Virus (RSV) Therapeutics Picture

    • Table Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Respiratory Syncytial Virus (RSV) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Respiratory Syncytial Virus (RSV) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Palivizumab Consumption and Growth Rate (2017-2022)

    • Figure Global Ribavirin Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Palivizumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ribavirin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Respiratory Syncytial Virus (RSV) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Respiratory Syncytial Virus (RSV) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Johnson and Johnson Services Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Services Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Services Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table Celltrion Inc (South Korea) (Foundation Year, Company Profile and etc.)

    • Table Celltrion Inc (South Korea) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Inc (South Korea) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table Bausch Health Companies Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Companies Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table Enanta Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Enanta Pharmaceuticals, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Enanta Pharmaceuticals, Inc (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table AstraZeneca (UK) (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca (UK) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca (UK) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table Sanofi (France) (Foundation Year, Company Profile and etc.)

    • Table Sanofi (France) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi (France) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table AbbVie (US) (Foundation Year, Company Profile and etc.)

    • Table AbbVie (US) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie (US) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service

    • Table mAbxience (Spain) (Foundation Year, Company Profile and etc.)

    • Table mAbxience (Spain) Respiratory Syncytial Virus (RSV) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table mAbxience (Spain) Respiratory Syncytial Virus (RSV) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US